Search


Search Parameters








1 - 33 of 33 items
Subjectivity and autonomy: meanings and narratives with respect to discontinuing psychiatric drugs Open Access
Tatiana Castillo Parada

Reduction of social coverage for symptomatic slow-acting drugs for osteoarthritis: a disinvestment initiative in Argentina, 2015-2017 Open Access
Martín A. Urtasun, María Noble, Martín Cañás, Julián Bustin, Ricardo C. Mastai, Alejandro J. Regueiro

The impact of researchers loyal to Big Pharma on the ethics and quality of clinical trials in Latin America Open Access
Antonio Ugalde, Núria Homedes

Medicamentos
Therapeutic value and price of the new pharmaceuticals commercialized in Argentina: Are they worth what they cost? Open Access
Martín Cañás, Héctor Omar Buschiazzo, Martín Alejandro Urtasun

Antipsychotics for schizophrenia: the paradigm of psychiatric drugs Open Access
Emilio Pol Yanguas

Circulation of information on drugs and other substances to increase cognitive performance: a study of a Brazilian blog (2015-2017) Open Access
Bruno Pereira de Castro, Elaine Reis Brandão

Drug Policies: prevention, participation and harm reduction Open Access
Oriol Romaní

Public policies for people who use drugs: Strategies for the elimination of stigma and the promotion of human rights Open Access
Antoniu Llort Suárez, Rafael Clua-García

Four words regarding clinical trials: science/profit, risks/benefits Open Access
Antonio Ugalde, Núria Homedes

Cartography of psychoactive heterotopias: a look at the medical, legal and social discourses regarding drug use Open Access
Paloma Massó

Pills for profits. The transformation of the pharmaceutical industry Open Access
Antonio Ugalde, Núria Homedes

Alternatives to the drug research and development model Open Access
Germán Velásquez

The temporal dimension of drugs: A sociological analysis based on a category key to the study of health-disease-care processes Open Access
Victoria Sánchez Antelo

Argentinian women and the uses of drugs: A sociohistorical analysis of female drug use in Argentina (1860-1930) Open Access
Victoria Sánchez Antelo

Psychiatric medicalization in three Brazilian women’s prisons: an ethnographic approach to the itineraries of criminalization, pathologization and pharmaceuticalization Open Access
Laura Ordoñez-Vargas, Claudia Margarita Cortés-García

Medicinal cannabis: beyond the myth, just another (herbal) drug Open Access
Paulo Cáceres Guido

Living with psychotropic drugs: A community photovoice study in people with high treatment adherence in Southeastern Spain Open Access
Francisco Martínez-Granados, Erica Briones-Vozmediano, Elena Ronda

Clinical trials in Latin America: implications for the sustainability and safety of pharmaceutical markets and the wellbeing of research subjects Open Access
Núria Homedes, Antonio Ugalde

The use of placebos in phase III clinical trials in Brazil Open Access
Gustavo Butzge Rubenich, Stephanie Tomasi Heck, Fernando Hellmann, Bruno Rodolfo Schlemper Junior

Substances considered addictive: prohibition, harm reduction and risk reduction Open Access
Eduardo L. Menéndez

Contributions towards an “essential” medicine strategy for Latin America Open Access
Gianni Tognoni

A critical examination of public policies related to indigenous health, traditional medicine, and interculturality in Mexico (1990-2016) Open Access
Roberto Campos Navarro, Edith Yesenia Peña Sánchez, Alfredo Paulo Maya

Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights Open Access
Raúl Allard Soto

The medication cycle: its impact on access to and adequate use of drugs Open Access
Homedes Núria, Ugalde Antonio

Managing pleasures and harms: An ethnographic study of drug consumption in public spaces, homes and drug consumption rooms Open Access
Rafael Clua-García

Narrating the narco world: a dialogue with Cristian Alarcón and Philippe Bourgois Open Access
Cristian Alarcón, Philippe Bourgois

Benzodiazepine and Z-drug consumption in a national social security organization in Argentina: rational or excessive use? Open Access
Gustavo Marin, Julieta Del Mauro, Lupe Marin, Martin A. Urtasun, Gina Marin, Daniel Nucher, Carlos Dacher, Dario Diaz Perez, Martín Cañás

Leftover and expired medicines in households: Is their storage and disposal a public health problem? Open Access
Juan Martín Calderón, Mónica Tarapués

Latin America: capital accumulation, health, and the role of international institutions Open Access
Antonio Ugalde, Núria Homedes

Interest in disinterestedness in the epidemiology of health systems and services Open Access
Hugo Spinelli

Ethics in the use of psychedelics: The definition of illicit drugs from the perspective of critical bioethics Open Access
Sergio Alexandre Liblik, Thiago Rocha da Cunha, Carmem Silvia da Fonseca Kummer Liblik, Diego Nicolás Biscioni, Dennys Robson Girardi

Evaluation of public drug provision policies for type 2 diabetes mellitus in Argentina: a case study Open Access
María Eugenia Elorza, Nebel Silvana Moscoso, Nadia Vanina Ripari

The precautionary principle in biomedical research, safety, post-research obligations and alleged therapeutic efficacy of experimental drugs: Violations of patient dignity Open Access
Sergio Eduardo Gonorazky

1 - 33 of 33 items